Delivery Order SPE2DB20D3104-SPE2DB25FV7X5
Award Date
6/4/25
Potential Completion Date
6/5/25
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of HUMALOG 100 UNIT/ML VIAL 10ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 9, 2022, with a ceiling value of $2,277.00 and a completion date of November 10, 2022. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
This federal contract award is for the delivery of HUMALOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,804.82 and was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 6, 2025. This award is not associated with a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,413.30, is a delivery order for the supply of HUMALOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of March 19, 2025 and is a firm fixed-price contract. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of HUMALOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $2,355.50 and a period of performance through April 9, 2025. The contract is a delivery order, with a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
The federal contract award is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 3, 2025, with a ceiling value of $1,324.65 and a completion date of January 6, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. Amerisourcebergen holds a significant Indefinite...
This federal contract award is for the delivery of HUMALOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Firm Fixed Price contract. The $5,464.80 award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 12, 2024, with a completion date of June 13, 2024. The contract is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This federal contract award, valued at $1,365.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMALOG 100 UNIT/ML VIAL 10ML, a prescription medication. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued up to...
This federal contract award, identified as SPE2DB22D1200|SPE2DB25FN0NR, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMALOG 100 UNIT/ML VIAL 10ML, a medical product, with a ceiling value of $1,076.72 and a completion date of February 25, 2025. The contract is structured as a Delivery Order under a larger Indefinite Delivery Contract...
The federal contract award, with ID SPE2DX15D1053|SPE2DX24F6MKG, is for the delivery of HUMALOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, to the U.S. Department of Defense (DoD) Medical Supply Chain. The firm-fixed-price contract has a ceiling value of $1,639.44 and an ultimate completion date of May 20, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, through its Corporate Office division. This contract is not set aside for a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,092.96 firm fixed-price delivery order is for the supply of HUMALOG 100 UNIT/ML VIAL 10ML, a medication used to treat diabetes. The contract has an ultimate completion date of May 8, 2023 and was awarded on May 5, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...